Neuried/Nesle, 8 July 2026 – AMSilk, a global leader in biotech produced silk materials, today announced a significant expansion of its partnership with Ajinomoto Foods Europe (AFE), marking a key step in scaling the industrial production of its silk proteins. Building on the collaboration first established in 2023, the two companies have now entered into […]
Senior executive across industrial biotechnology and consumer markets with strong expertise in commercialization joins AMSilk as the Company advances from development through scale-up to market growth The announcement follows the launch of biotech silk protein yarns in Balenciaga Spring 2026 collection Neuried, Germany, June 17, 2026 – AMSilk GmbH (“AMSilk”), a global leader in advanced […]
First commercially available products using AMSilk’s biotech silk protein yarns Demonstrating a scalable, low impact alternative to conventional silk within luxury fashion Designed for resilient, transparent and regionally integrated supply chains Neuried, Germany, January 21, 2026 – AMSilk GmbH (“AMSilk”), a global leader in advanced biomaterials made from silk proteins, today announced that its bioengineered […]
Dedicated manufacturing line for AMSilk high-performance silk proteins High tech industrial biomaterials meet leading apparel brands’ demand for scalable, sustainable, alternatives Expanding Evonik’s portfolio of precision biosolutions ESSEN, Germany and NEURIED, Germany, Sept. 25, 2025 – Evonik and AMSilk, a global leader in advanced biomaterials based on silk proteins, have deepened their collaboration with a long-term agreement to produce […]
Funding enables AMSilk to scale industrial production and meet global customer demand for biotech produced silk-based protein materials The financing round was led by existing investor ATHOS (AT Newtec), with strong participation from fellow existing investors MIG Capital and Novo Holdings The total EUR 52M includes EUR 30M in cash and EUR 22M in convertible […]
